Precise execution

MC Services is...

Client News



… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.


read more


MC Services hosted Press Lounge at the BIO-Europe 2016 in Cologne


This fall, Cologne hosted Europe’s largest partnering conference for the global biotechnology industry - BIO-Europe®. The event took place November 7-9 and had over 3,600 attendees from over 60 countries. MC Services was supporting BIO-Europe® as media partner and hosted the new conference Press Lounge: Centrally located in the exhibit hall – in the midst of activities – journalists were able to retreat to a quiet, fully-equipped work station or use the lounge area to conduct interviews or network with industry representatives.

Twitter: #BIOEurope 2016 #PressLounge


MC Services, EBD Group, BIO.NRW and LaBiotech.eu joined forces for BIO-Europe 2016 live blog


MC Services led a joint initiative with EBD Group, BIO.NRW LaBiotech.eu at BIO-Europe to introduce science journalist students from the “Kölner Journalistenschule” and the TU Dortmund to the biosciences industry. The students were invited to BIO-Europe to conduct interviews with participants and report their impressions of the event, as well as highlights from panels, company presentations and discussions. This content is available in a blog, designed for experts and generalists alike, with the aim of connecting the conference with international audiences and relevant local communities.


Please also follow us on Twitter (@MCServicesAG; #BIOEurope 2016)


The blog is available here


MC Services introduces “BIT” - the BIO-Europe® Investor Talks

During the course of the BIO-Europe 2016, MC Services conducted video interviews with some of the most prominent European investors/VCs in the life sciences space to capture their thoughts on current and future trends in the sector, how the investors are addressing these trends and what exit paths they are realistically seeing in Europe.


The interviews are available here

Cinfa Biotech publishes clinical data abstract at the 58th American Society of Hematology (ASH) Annual Meeting 2016


MagForce AG supports NOA Winter School 2016 from December 01-02 in Münster, Germany


VAXIMM Presents Preclinical Data on Three Novel Oral T-Cell Cancer Immunotherapies at EORTC-NCI-AACR Symposium


co.don AG: early submission of document packages for EU marketing authorisation


AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes


SYGNIS AG announces publication in “Nature Communications” of the TruePrime™ novel method for whole genome amplification


Ergomed strengthens PrimeVigilance with acquisition of European pharmacovigilance and regulatory services business, PharmInvent


New Success with the Development of a Depolymerization Process at 100% of Plastic Bottles


MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application For Guselkumab in Europe


SYGNIS AG reinforces its proteomics portfolio with two patents granted in Europe and China


ABIVAX to Host Key Opinion Leader Luncheon for Investors Focused on Novel Approaches to HIV Therapy


RedHill Biopharma Announces YELIVA(TM) (ABC294640) Poster Presentation at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium